These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15788416)

  • 61. The role of plasminogen-plasmin system in cancer.
    Kwaan HC; McMahon B
    Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasminogen receptors.
    Miles LA; Plow EF; Waisman DM; Parmer RJ
    J Biomed Biotechnol; 2012; 2012():130735. PubMed ID: 23226936
    [No Abstract]   [Full Text] [Related]  

  • 63. Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.
    Garraud M; Khacef K; Vion AC; Leconte C; Yin M; Renard JM; Marchand-Leroux C; Boulanger CM; Margaill I; Beray-Berthat V
    J Neurol Sci; 2016 Nov; 370():187-195. PubMed ID: 27772757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of the Equilibrium between Closed and Open Conformations of Annexin A2 by N-Terminal Phosphorylation and S100A4-Binding.
    Ecsédi P; Kiss B; Gógl G; Radnai L; Buday L; Koprivanacz K; Liliom K; Leveles I; Vértessy B; Jeszenői N; Hetényi C; Schlosser G; Katona G; Nyitray L
    Structure; 2017 Aug; 25(8):1195-1207.e5. PubMed ID: 28669632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A mediator of cell surface-specific plasmin generation.
    Brownstein C; Falcone DJ; Jacovina A; Hajjar KA
    Ann N Y Acad Sci; 2001 Dec; 947():143-55; discussion 155-6. PubMed ID: 11795262
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery.
    Ishii H; Yoshida M; Hiraoka M; Hajjar KA; Tanaka A; Yasukochi Y; Numano F
    Circ Res; 2001 Dec; 89(12):1240-5. PubMed ID: 11739291
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.
    Lacroix R; Sabatier F; Mialhe A; Basire A; Pannell R; Borghi H; Robert S; Lamy E; Plawinski L; Camoin-Jau L; Gurewich V; Angles-Cano E; Dignat-George F
    Blood; 2007 Oct; 110(7):2432-9. PubMed ID: 17606760
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulation of Ion Channels and Receptors by p11 (S100A10).
    Seo JS; Svenningsson P
    Trends Pharmacol Sci; 2020 Jul; 41(7):487-497. PubMed ID: 32418644
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
    Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
    Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The topology of plasminogen binding and activation on the surface of human breast cancer cells.
    Andronicos NM; Ranson M
    Br J Cancer; 2001 Sep; 85(6):909-16. PubMed ID: 11556845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.
    Yang W; Mei FC; Cheng X
    FASEB J; 2018 Apr; 32(4):2212-2222. PubMed ID: 29217666
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
    Liu Y; Wang Z; Jiang M; Dai L; Zhang W; Wu D; Ruan C
    Leuk Res; 2011 Jul; 35(7):879-84. PubMed ID: 21146216
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.
    Valapala M; Thamake SI; Vishwanatha JK
    J Cell Sci; 2011 May; 124(Pt 9):1453-64. PubMed ID: 21486955
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.
    Siao CJ; Tsirka SE
    J Neurosci; 2002 May; 22(9):3352-8. PubMed ID: 11978811
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The annexin A2 system and angiogenesis.
    Liu W; Hajjar KA
    Biol Chem; 2016 Oct; 397(10):1005-16. PubMed ID: 27366903
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.
    Kesavan K; Ratliff J; Johnson EW; Dahlberg W; Asara JM; Misra P; Frangioni JV; Jacoby DB
    J Biol Chem; 2010 Feb; 285(7):4366-74. PubMed ID: 20018898
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
    Bharadwaj AG; Kempster E; Waisman DM
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody.
    Hernández JL; Padilla L; Dakhel S; Coll T; Hervas R; Adan J; Masa M; Mitjans F; Martinez JM; Coma S; Rodríguez L; Noé V; Ciudad CJ; Blasco F; Messeguer R
    PLoS One; 2013; 8(9):e72480. PubMed ID: 24023743
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel mechanism of plasminogen activation in epithelial and mesenchymal cells.
    Bydoun M; Sterea A; Weaver ICG; Bharadwaj AG; Waisman DM
    Sci Rep; 2018 Sep; 8(1):14091. PubMed ID: 30237490
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
    Radestock Y; Willing C; Kehlen A; Hoang-Vu C; Hombach-Klonisch S
    Mol Cancer Res; 2010 Apr; 8(4):494-506. PubMed ID: 20332215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.